Biocon
Lakshmana Rao Kenguva has a background in pharmaceutical sciences, holding a B.Voc degree in manufacturing and technology pharmaceutical chemistry from the Tata Institute of Social Sciences, obtained in February 2019. Lakshmana began professional experience at Dr. Reddy's as a Warehouse Team Member from August 2015 to January 2021, followed by a role as an Executive at Solara Active Pharma Sciences from February 2021 to September 2022. Currently, Lakshmana serves as an Executive at Biocon since December 2022.
This person is not in any teams
This person is not in any offices
Biocon
21 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.